Jazz Pharmaceuticals JAZZ Deferred taxes
Deferred taxes at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's deferred taxes?
- Jazz Pharmaceuticals (JAZZ) reported deferred taxes of -$66.2M in Q1 2026.
- How has Jazz Pharmaceuticals's deferred taxes changed year-over-year?
- Jazz Pharmaceuticals's deferred taxes decreased by 51.1% year-over-year, from -$43.8M to -$66.2M.
- What is the long-term trend for Jazz Pharmaceuticals's deferred taxes?
- Over 3 years (2022 to 2025), Jazz Pharmaceuticals's deferred taxes has grown at a 15.0% compound annual growth rate (CAGR), from -$292.25M to -$444.97M.
- What does deferred taxes mean?
- The impact on taxes that will be paid or saved in future periods due to current accounting differences.
- How do you interpret deferred taxes?
- A large deferred tax benefit can signal future tax savings, while a large expense indicates future tax liabilities that will eventually require cash payment.
- How does deferred taxes compare across companies?
- Standard tax accounting item found in the cash flow statement for all large corporations.